Investor profile
MRL Ventures Fund has backed 3 European tech companies across 4 funding rounds between 2022 and 2023, joining rounds totalling €202M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| EyeBiotech | UK | 2 | €118M |
| Ambagon Therapeutics | Netherlands | 1 | €75M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Ambagon Therapeutics | Series A | €75M | 2022-01 |
| EyeBiotech | Series A | €61M | 2023-11 |
| EyeBiotech | Series A | €57M | 2022-02 |
| Anavo Therapeutics |
| Seed |
| €8.5M |
| 2023-05 |
